Trial intelligence / Profile preview

Lexapro in Night Eating Syndrome

NCT01401595Phase 3Completed

Sponsor
University of Pennsylvania
Start
Dec 2009
Primary completion
Sep 2011
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of escitalopram in Night eating syndrome (NES), sponsored by University of Pennsylvania. Started Dec 2009; status: completed.

02

Drugs

escitalopram
03

Conditions

Night eating syndrome (NES)

Beyond the preview

Go deeper on NCT01401595.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01401595.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call